Amdocs (NASDAQ:DOX – Get Free Report) will be releasing its earnings data after the market closes on Wednesday, May 8th. Analysts expect Amdocs to post earnings of $1.43 per share for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link.
Amdocs (NASDAQ:DOX – Get Free Report) last issued its quarterly earnings data on Tuesday, February 6th. The technology company reported $1.56 EPS for the quarter, beating the consensus estimate of $1.40 by $0.16. Amdocs had a return on equity of 17.79% and a net margin of 11.30%. The firm had revenue of $1.25 billion during the quarter, compared to analyst estimates of $1.24 billion. During the same quarter in the prior year, the business posted $1.33 EPS. The business’s revenue for the quarter was up 5.0% compared to the same quarter last year. On average, analysts expect Amdocs to post $6 EPS for the current fiscal year and $7 EPS for the next fiscal year.
Amdocs Stock Up 0.3 %
Shares of DOX stock opened at $83.90 on Monday. The stock’s fifty day moving average price is $88.95 and its 200 day moving average price is $87.47. Amdocs has a 1-year low of $78.38 and a 1-year high of $99.75. The company has a market cap of $9.86 billion, a price-to-earnings ratio of 17.97, a price-to-earnings-growth ratio of 1.36 and a beta of 0.70. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.29 and a quick ratio of 1.29.
Amdocs Increases Dividend
Analyst Ratings Changes
Several analysts have weighed in on DOX shares. Citigroup boosted their target price on shares of Amdocs from $96.00 to $104.00 and gave the stock a “buy” rating in a research report on Wednesday, January 17th. Barclays upped their target price on Amdocs from $105.00 to $115.00 and gave the company an “overweight” rating in a research report on Thursday, February 8th. Finally, StockNews.com cut Amdocs from a “strong-buy” rating to a “buy” rating in a research report on Friday, March 15th. Five investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, Amdocs presently has a consensus rating of “Buy” and an average target price of $108.60.
Read Our Latest Analysis on DOX
Amdocs Company Profile
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Recommended Stories
- Five stocks we like better than Amdocs
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- MarketBeat Week in Review – 4/29 – 5/3
- What is a Low P/E Ratio and What Does it Tell Investors?
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.